• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与婴儿期起病型糖尿病和中度 DEND 相关的新型 KCNJ11 框移缺失突变的功能特征:K(ATP)通道活性增加与通道表达缺失之间的较量。

Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between K(ATP) gain of channel activity and loss of channel expression.

机构信息

Department of Cell Biology and Physiology, and Center for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.

出版信息

PLoS One. 2013 May 7;8(5):e63758. doi: 10.1371/journal.pone.0063758. Print 2013.

DOI:10.1371/journal.pone.0063758
PMID:23667671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3646792/
Abstract

ATP-sensitive potassium (K(ATP)) channels are widely distributed in various tissues and cell types where they couple cell metabolism to cell excitability. Gain of channel function (GOF) mutations in the genes encoding Kir6.2 (KCNJ11) or the associated regulatory ssulfonylurea receptor 1 subunit (ABCC8), cause developmental delay, epilepsy and neonatal diabetes (DEND) due to suppressed cell excitability in pancreatic β-cells and neurons. The objective of this study was to determine the molecular basis of infancy-onset diabetes and a mild form of intermediate DEND, resulting from a novel KCNJ11 in frame mutation plus deletion. The naturally occurring Kir6.2 mutation plus deletion (Ser225Thr, Pro226_Pro232del) as well as the isolated S225T mutation or isolated del226-232 deletion were coexpressed with SUR1 in COS cells in homozygous or heterozygous states. The protein expression and gating effects of the resulting channels were assessed biochemically and electrophysiologically. For both the deletion and point mutations, simulated heterozygous expression resulted in overall increased conductance in intact cells in basal conditions and rightward shifted ATP dose-response curves in excised patches, due to increased intrinsic open probability. Interestingly, homomeric channels for the combined deletion/mutation, or for the deletion alone, showed dramatically reduced channel expression at the cell membrane, which would underlie a reduced function in vivo. These results demonstrate that both the mis-sense mutation and the deleted region in the Kir6.2 subunit are important for control of the intrinsic channel gating and suggest that the clinical presentation could be affected by the competition between loss-of-function by reduced trafficking and enhanced channel gating.

摘要

三磷酸腺苷敏感性钾 (K(ATP)) 通道广泛分布于各种组织和细胞类型中,它们将细胞代谢与细胞兴奋耦联。编码 Kir6.2 (KCNJ11) 的基因或相关的磺酰脲受体 1 亚基 (ABCC8) 的通道功能获得性 (GOF) 突变导致发育迟缓、癫痫和新生儿糖尿病 (DEND),原因是胰腺 β 细胞和神经元的细胞兴奋受到抑制。本研究的目的是确定婴儿期发病的糖尿病和轻度中间 DEND 的分子基础,这是由于新型 KCNJ11 框移突变加缺失引起的。天然存在的 Kir6.2 突变加缺失 (Ser225Thr,Pro226_Pro232del) 以及分离的 S225T 突变或分离的 del226-232 缺失与 SUR1 在 COS 细胞中以纯合或杂合状态共同表达。通过生化和电生理方法评估所得通道的蛋白表达和门控效应。对于缺失和点突变,模拟杂合表达导致在基础条件下完整细胞的整体电导增加,并且在分离的斑块中 ATP 剂量反应曲线右移,这是由于内在开放概率增加所致。有趣的是,对于组合缺失/突变或单独缺失的同型通道,在细胞膜上显示出明显减少的通道表达,这将是体内功能降低的基础。这些结果表明,Kir6.2 亚基中的错义突变和缺失区域对于控制内在通道门控都很重要,并表明临床表型可能受到减少转运和增强通道门控之间竞争的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/4a687959e80b/pone.0063758.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/2c6a278e95f4/pone.0063758.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/3019d474ce54/pone.0063758.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/516b22a72f1c/pone.0063758.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/af46c5306993/pone.0063758.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/70e451b1d141/pone.0063758.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/4a687959e80b/pone.0063758.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/2c6a278e95f4/pone.0063758.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/3019d474ce54/pone.0063758.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/516b22a72f1c/pone.0063758.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/af46c5306993/pone.0063758.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/70e451b1d141/pone.0063758.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf2/3646792/4a687959e80b/pone.0063758.g006.jpg

相似文献

1
Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between K(ATP) gain of channel activity and loss of channel expression.一种与婴儿期起病型糖尿病和中度 DEND 相关的新型 KCNJ11 框移缺失突变的功能特征:K(ATP)通道活性增加与通道表达缺失之间的较量。
PLoS One. 2013 May 7;8(5):e63758. doi: 10.1371/journal.pone.0063758. Print 2013.
2
Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.胰腺 K(ATP) 通道 SUR1(ABCC8)亚单位的复合杂合突变通过扰乱 Kir6.2 和 SUR1 亚单位之间的偶联导致新生儿糖尿病。
Channels (Austin). 2012 Mar-Apr;6(2):133-8. doi: 10.4161/chan.19980. Epub 2012 Mar 1.
3
Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.由磺酰脲受体 1 突变引起的新生儿糖尿病:ATP 敏感性钾通道表达和 Mg-核苷酸门控缺陷之间的相互作用。
J Clin Endocrinol Metab. 2010 Dec;95(12):E473-8. doi: 10.1210/jc.2010-1231. Epub 2010 Sep 1.
4
A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.Kir6.2 孔道内口处的门控突变与 DEND 综合征相关。
EMBO Rep. 2005 May;6(5):470-5. doi: 10.1038/sj.embor.7400393.
5
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.与新生儿糖尿病或伴有神经学特征的新生儿糖尿病相关的Kir6.2突变的分子基础。
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17539-44. doi: 10.1073/pnas.0404756101. Epub 2004 Dec 6.
6
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.一种导致DEND综合征的新型突变:一种可治疗的胰腺和脑部通道病。
Neurology. 2007 Sep 25;69(13):1342-9. doi: 10.1212/01.wnl.0000268488.51776.53. Epub 2007 Jul 25.
7
Molecular and clinical features of K -channel neonatal diabetes mellitus in Japan.日本 K 通道新生儿糖尿病的分子和临床特征。
Pediatr Diabetes. 2017 Nov;18(7):532-539. doi: 10.1111/pedi.12447. Epub 2016 Sep 29.
8
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.导致DEND综合征的磺酰脲受体SUR1突变(F132L)的作用机制。
Hum Mol Genet. 2007 Aug 15;16(16):2011-9. doi: 10.1093/hmg/ddm149. Epub 2007 Jun 21.
9
Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.与新生儿糖尿病和神经症状相关的 Kir6.2 滑动螺旋突变之间的相互作用。
Hum Mol Genet. 2010 Mar 15;19(6):963-72. doi: 10.1093/hmg/ddp554. Epub 2009 Dec 18.
10
An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.Kir6.2(KCNJ11)基因的框内缺失导致新生儿糖尿病,揭示了Kir6.2与SUR1之间的相互作用位点。
J Clin Endocrinol Metab. 2009 Jul;94(7):2551-7. doi: 10.1210/jc.2009-0159. Epub 2009 Apr 7.

引用本文的文献

1
rs5219 Gene Polymorphism Is Associated With T2DM in a Population of Bangladesh: A Case-Control Study.rs5219基因多态性与孟加拉人群2型糖尿病的相关性:一项病例对照研究。
Int J Endocrinol. 2025 May 2;2025:5834412. doi: 10.1155/ije/5834412. eCollection 2025.
2
From glucose sensing to exocytosis: takes from maturity onset diabetes of the young.从葡萄糖感应到胞吐作用:从青年发病的成年型糖尿病说起。
Front Endocrinol (Lausanne). 2023 May 15;14:1188301. doi: 10.3389/fendo.2023.1188301. eCollection 2023.
3
K channel mutations in congenital hyperinsulinism: Progress and challenges towards mechanism-based therapies.

本文引用的文献

1
Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation.格列吡嗪可改善伴有 KCNJ11/S225T、del226-232 突变的糖尿病患儿的运动协调和葡萄糖稳态。
Pediatr Diabetes. 2012 Dec;13(8):656-60. doi: 10.1111/j.1399-5448.2012.00874.x. Epub 2012 Jun 14.
2
Congenital hyperinsulinism and glucose hypersensitivity in homozygous and heterozygous carriers of Kir6.2 (KCNJ11) mutation V290M mutation: K(ATP) channel inactivation mechanism and clinical management.先天性高胰岛素血症和葡萄糖敏感性在 Kir6.2(KCNJ11)突变 V290M 突变的纯合子和杂合子携带者中:K(ATP)通道失活机制和临床管理。
Diabetes. 2011 Jan;60(1):209-17. doi: 10.2337/db10-0731. Epub 2010 Oct 27.
3
先天性高胰岛素血症中的 K 通道突变:基于机制的治疗方法的进展和挑战。
Front Endocrinol (Lausanne). 2023 Mar 28;14:1161117. doi: 10.3389/fendo.2023.1161117. eCollection 2023.
4
A Cantú syndrome mutation produces dual effects on KATP channels by disrupting ankyrin B regulation.坎图综合征突变通过破坏锚蛋白 B 的调节对 KATP 通道产生双重影响。
J Gen Physiol. 2023 Jan 2;155(1). doi: 10.1085/jgp.202112995. Epub 2022 Oct 26.
5
Subcellular trafficking and endocytic recycling of K channels.K 通道的亚细胞运输和内吞回收。
Am J Physiol Cell Physiol. 2022 Jun 1;322(6):C1230-C1247. doi: 10.1152/ajpcell.00099.2022. Epub 2022 May 4.
6
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome.坎图综合征小鼠模型骨骼肌中KATP通道活性过高的病理生理后果及对格列本脲的药理反应
Front Pharmacol. 2020 Nov 30;11:604885. doi: 10.3389/fphar.2020.604885. eCollection 2020.
7
Intellectual Disability and Potassium Channelopathies: A Systematic Review.智力残疾与钾通道病:一项系统综述
Front Genet. 2020 Jun 23;11:614. doi: 10.3389/fgene.2020.00614. eCollection 2020.
8
New insights into K channel gene mutations and neonatal diabetes mellitus.钾通道基因突变与新生儿糖尿病的新见解。
Nat Rev Endocrinol. 2020 Jul;16(7):378-393. doi: 10.1038/s41574-020-0351-y. Epub 2020 May 6.
9
Control of Kir channel gating by cytoplasmic domain interface interactions.通过细胞质结构域界面相互作用对钾离子通道门控的调控
J Gen Physiol. 2017 May 1;149(5):561-576. doi: 10.1085/jgp.201611719. Epub 2017 Apr 7.
10
Differential mechanisms of Cantú syndrome-associated gain of function mutations in the ABCC9 (SUR2) subunit of the KATP channel.卡恩图综合征相关的钾离子通道ATP敏感性钾通道(KATP通道)ABCC9(SUR2)亚基功能获得性突变的差异机制
J Gen Physiol. 2015 Dec;146(6):527-40. doi: 10.1085/jgp.201511495.
Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.由于 ABCC8 和 KCNJ11 的激活突变导致的永久性新生儿糖尿病。
Rev Endocr Metab Disord. 2010 Sep;11(3):193-8. doi: 10.1007/s11154-010-9149-x.
4
Ankyrin-B regulates Kir6.2 membrane expression and function in heart.锚蛋白-B 调节心脏中 Kir6.2 的膜表达和功能。
J Biol Chem. 2010 Sep 10;285(37):28723-30. doi: 10.1074/jbc.M110.147868. Epub 2010 Jul 7.
5
Crystal structure of the eukaryotic strong inward-rectifier K+ channel Kir2.2 at 3.1 A resolution.真核强内向整流钾通道 Kir2.2 的晶体结构,分辨率为 3.1Å。
Science. 2009 Dec 18;326(5960):1668-74. doi: 10.1126/science.1180310.
6
Dual role of K ATP channel C-terminal motif in membrane targeting and metabolic regulation.ATP敏感性钾通道C末端基序在膜靶向和代谢调节中的双重作用。
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16669-74. doi: 10.1073/pnas.0907138106. Epub 2009 Sep 15.
7
Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.糖尿病和高胰岛素血症中编码胰腺β细胞K(ATP)通道亚基Kir6.2(KCNJ11)和磺脲类受体1(ABCC8)的基因突变的更新
Hum Mutat. 2009 Feb;30(2):170-80. doi: 10.1002/humu.20838.
8
DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel.Kir6.2(KCNJ11)中的DEND突变揭示了一个对KATP通道ATP感知至关重要的灵活N端区域。
Biophys J. 2008 Nov 15;95(10):4689-97. doi: 10.1529/biophysj.108.138685. Epub 2008 Aug 15.
9
A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM).磺脲类受体-1(SUR1)的TMD0-L0区域中的一个突变(L225P)导致永久性新生儿糖尿病(PNDM)。
Diabetes. 2007 May;56(5):1357-62. doi: 10.2337/db06-1746. Epub 2007 Feb 22.
10
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.导致新生儿糖尿病的六种Kir6.2(KCNJ11)突变的功能分析
Pflugers Arch. 2006 Dec;453(3):323-32. doi: 10.1007/s00424-006-0112-3. Epub 2006 Sep 22.